CLASS II Drug recall · Reported 30 Sep 2015 · FDA Enforcement Report

Refresh Lacri-Lube (Mineral Oil recalled by Allergan Sales

Allergan Sales is recalling Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, distributed nationwide in the US. The recall was initiated on 24 Aug 2015 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: a) 84746, Exp 04/17; 84987, 85087, Exp 05/17; 85359, Exp 06/17; 85721, Exp 07/17; 86045, Exp 08/17; 86406, Exp 09/17; 86594, Exp 10/17; 87021, Exp 11/17; and b) 86470, Exp 09/17; 86829, Exp 10/17; 87105, Exp 11/17
NDC0023-0312
UPC300230312042, 300230312073
Quantity recalled320,713 tubes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1817-2015
FDA event ID
72016
Recalling firm
Allergan Sales, Waco, TX
Manufacturer
Allergan, Inc.
Classification
Class II
Status
Terminated
Recall initiated
24 Aug 2015
FDA classified
22 Sep 2015
Reported
30 Sep 2015
Type
Voluntary: Firm initiated
Customers notified by
N/A
Reason category
Particulate Matter
Drug class
Eye Drops

Timeline

24 Aug 2015Recall initiated by company
22 Sep 2015Classified by FDA+29 days
30 Sep 2015Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

Product as listed by the FDA

Refresh Lacri-Lube (Mineral Oil 42.5% and White Petrolatum 56.8%) Lubricant Eye Ointment, packaged in a) Net wt. 0.12 oz (3.5 g) tubes (NDC 0023-0312-04) UPC 3 0023-0312-04 2 and b) Net wt. 0.25 oz (7 g) tubes (NDC 0023-0312-07) UPC 3 0023-0312-07 3, Allergan, Inc., 2525 Dupont Drive, Irvine, CA 92612.

Where it was distributed

Nationwide, Puerto Rico, and Barbados

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Presence of Particulate Matter: Due to customer complaints of small black particles, identified as part of the ointment tube cap, generated by the action of unscrewing the cap from the aluminum tube and potentially introducing the particle into the product.

Which lots are affected?

Lot #: a) 84746, Exp 04/17; 84987, 85087, Exp 05/17; 85359, Exp 06/17; 85721, Exp 07/17; 86045, Exp 08/17; 86406, Exp 09/17; 86594, Exp 10/17; 87021, Exp 11/17; and b) 86470, Exp 09/17; 86829, Exp 10/17; 87105, Exp 11/17

Where was it sold?

Nationwide, Puerto Rico, and Barbados

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 72016

More recalls from Allergan Sales

All 14

Other Mineral Oil recalls

All 4